Skip to content

Clinical trials

Primary Myelofibrosis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Country / region: Taiwan Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20131
20151
20161
20171
20181
20192
20204
20215
20221
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting7
Recruiting4
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Novartis Pharmaceuticals5
Geron Corporation2
Karyopharm Therapeutics Inc2
Sierra Oncology LLC - a GSK company2
GlaxoSmithKline1
Incyte Corporation1
Kartos Therapeutics, Inc.1
National Taiwan University Hospital1
PharmaEssentia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis24
Myeloproliferative Disorders6
Neoplasms5
Anemia3
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Bone Marrow Diseases1
Hematologic Diseases1
Leukemia, Myelomonocytic, Chronic1
Mastocytosis, Systemic1

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.